“…Various treatment modalities have been used in the treatment of RAP, including direct laser photocoagulation, transpupillary thermotherapy, surgical removal, and photodynamic therapy (PDT) with verteporfin (Visudyne; Novartis Pharma AG, Basel, Switzerland) with or without concomitant intravitreal triamcinolone [5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22]. However, often their results were disappointing, leading to limited success or to poor functional results, while in some cases concerns were aroused with regard to risks of severe complications [5,16,17].…”